You might have heard the news already. The FDA approved Biogen's drug Aduhelm (aducanumab). Everyone seems to be celebrating. See @jimcaster 's post :
healthunlocked.com/cure-par...
Not so fast, says this opinion piece from a Bloomberg writer:
bloomberg.com/opinion/artic...
RKM
good article. Lays it all out.
Why I am not joyous about this announcement:
- at $56,000 per year / person, it will likely take money from other parts of health care;
- it signals an acceptance of post-hoc analysis: if a trial gives the wrong answer, collect more data, and try again
" if a trial gives the wrong answer, collect more data, and try again."
don't tell the believers and those who own Biogen stock about "post-hoc analysis" problems...(i.e. after the fact manipulation of the data).
+* 6/27 day 41 of taking B1 as TTDF: :-) 
Anti-Malaria Drugs Treat PD?
Another potential PD therapeutic drug?
Parkinson's disease drug ropinirole safely slows the progression of amyotrophic lateral sclerosis
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial
